Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Phase 3 Trial of Biotherapy Using Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU)

NCT04176120 is registered in ClinicalTrials.gov with BioTissue Holdings, Inc as lead sponsor.

NCT NCT04176120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04176120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Phase 3 Trial of Biotherapy Using Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU)
Lead sponsor
BioTissue Holdings, Inc
Phase
Phase 3
Overall status
Completed
Start date
July 1, 2020
Completion date
June 12, 2024
Enrollment
220 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot infection, non-healing diabetic foot ulcer, non-healing wound